Back to search

Precision Tissue Ltd

12892249

active
ltd
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Negative net worth (-10)

Details

11 Belfont Walk Belfont Walk, London, N7 0SN
Incorporated 21/09/2020

Previously known as

Tissue Access For Patient Benefit Limited · until 25/07/2025

Compliance

Last accounts

31/03/2025

micro entity

Next accounts due

31/12/2026

On track

Confirmation statement

Last: 08/04/2026

Due 22/04/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Prof Brian Ritchie Davidson

director · Since 24/08/2022

DIRECTOR

SCOTTISH · ENGLAND · Age 68

Also on 4 other boards

Barry Fuller

director · Since 24/08/2022

DIRECTOR

BRITISH · ENGLAND · Age 78

Amir Gander

director · Since 24/08/2022

DIRECTOR

BRITISH · ENGLAND · Age 44

Brian Ritchie Davidson

director · Since 24/08/2022

Scottish · England · Age 68

Barry Fuller

director · Since 24/08/2022

British · England · Age 78

Amir Gander

director · Since 24/08/2022

British · England · Age 44

Former

Craig Macpherson

director · Resigned 24/08/2022

Persons with Significant Control

Brian Davidson

25–50% shares
25–50% votes

British · England · Age 78

11 Belfont Walk, Belfont Walk, London, N7 0SN

Notified 24/08/2022

Barry Fuller

25–50% shares
25–50% votes

British · England · Age 78

11 Belfont Walk, Belfont Walk, London, N7 0SN

Notified 24/08/2022

Prof Brian Ritchie Davidson

25–50% shares
25–50% votes

Scottish · England · Age 68

11 Belfont Walk, Belfont Walk, London, N7 0SN

Notified 24/08/2022

Amir Gander

25–50% shares
25–50% votes

British · England · Age 44

11 Belfont Walk, Belfont Walk, London, N7 0SN

Notified 24/08/2022

Former PSCs

Craig Macpherson

Ceased 24/08/2022

Change History

status → active
2026-08-22

Active

type → ltd
2026-08-22

Private Limited Company

address line1 → 11 Belfont Walk Belfont Walk
2026-08-22

11 BELFONT WALK

post town → London
2026-08-22

LONDON

officer appointed → DAVIDSON, Brian Ritchie, Prof
2026-08-22
officer appointed → FULLER, Barry
2026-08-22
officer appointed → GANDER, Amir
2026-08-22

CompanyRankvs 3678+ SIC 72110 peers
26

Financial strength13th percentile among SIC peers · 3/25
Employees0th percentile among SIC peers · 0/15
LiquidityCurrent ratio 0.02× · 2/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Charles River U.K. Limited
90
2Werfen Limited
90
3Biopharma Process Systems Limited
90
4Theradex (Europe) Limited
90
5Spicer Consulting Limited
90
6Exmoor Pharma Concepts Limited
90
7Ubc Late Stage (Uk) Limited
90
8Wuxi Apptec Uk Ltd
90
9Ccm Technologies Limited
90
10Bio - Diagnostics Limited
89
3678Precision Tissue Ltd
25
How is this score calculated?
Financial strength3/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

-£27k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

-£26k

Working capital

Current Assets

£567

Current Liabilities

£26k

Balance Sheet

Assets less current liabilities-£26k
Signed by Mr A Gander 30 December 2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.02-£822
20240.04-£25k
20230.96—

Derived from filed accounts. Not audited figures.